Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking. Although it ...

A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Early diagnosis of lung cancer may improve the prognosis, but many people aren’t aware they have it until it spreads. Screening tests may help detect the disease. Blood tests are not yet ...

Overall, the one-time LDCT diagnostic performance in the non-risk-based screening population had a sensitivity of 96.6%, a ...

Li Qiang, director of the respiratory and critical care medicine department at the hospital, said the patient had over 10 ...

Previous estimates had put this risk closer to ... Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment Apr. 9, 2025 — Researchers have discovered that 'DEAD ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Diliman has identified potential biomarkers or signs that can help with early lung cancer detection with the support of the ...

The Bloomfield woman has made it a mission to educate the public about lung cancer after losing her only son in 2021.